Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Clénet

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 18, 2018
Accurate prediction of vaccine stability under real storage conditions and during temperature excursionsDidier Clénet
Pharmaceutics|February 26, 2022
Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic ModelingAndreas Evers, Didier Clénet, Stefania Pfeiffer-Marek
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2019
A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidateDidier Clénet, Véronique Hourquet, Bertrand Woinet, et al.
International Journal of Pharmaceutics|October 2, 2021
Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccineChristophe Neyra, Didier Clénet, Marcia Bright, et al.
Pharmaceutics|May 27, 2026
Predictive Stability of Aggregation in Glycoconjugate Vaccines Using Advanced Kinetics Modeling and High-Throughput ScreeningTao Ju Cui, Didier Clénet, Martinus A H Capelle, et al.
Journal of Pharmaceutical Sciences|August 21, 2014
Advanced kinetic analysis as a tool for formulation development and prediction of vaccine stabilityDidier Clénet, Frédéric Imbert, Patricia Probeck, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 18, 2018
Biophysical virus particle specific characterization to sharpen the definition of virus stabilityDidier Clénet, Tatiana Vinit, Damien Soulet, et al.
Biotechnology and Bioengineering|July 23, 2021
Full-length G glycoprotein directly extracted from rabies virus with detergent and then stabilized by amphipols in liquid and freeze-dried formsDidier Clénet, Léna Clavier, Benoît Strobbe, et al.
Plos One|June 11, 2025
Bayesian optimization and machine learning for vaccine formulation developmentLillian Li, Sung-In Back, Jian Ma, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 10, 2026
Formulation and stability design spaces for a new yellow fever vaccineDidier Clénet, Noémie Mansois, Yawen Guo, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 18, 2018
Accurate prediction of vaccine stability under real storage conditions and during temperature excursionsDidier Clénet
Pharmaceutics|February 26, 2022
Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic ModelingAndreas Evers, Didier Clénet, Stefania Pfeiffer-Marek
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 16, 2019
A spray freeze dried micropellet based formulation proof-of-concept for a yellow fever vaccine candidateDidier Clénet, Véronique Hourquet, Bertrand Woinet, et al.
International Journal of Pharmaceutics|October 2, 2021
Predictive modeling for assessing the long-term thermal stability of a new fully-liquid quadrivalent meningococcal tetanus toxoid conjugated vaccineChristophe Neyra, Didier Clénet, Marcia Bright, et al.
Pharmaceutics|May 27, 2026
Predictive Stability of Aggregation in Glycoconjugate Vaccines Using Advanced Kinetics Modeling and High-Throughput ScreeningTao Ju Cui, Didier Clénet, Martinus A H Capelle, et al.
Journal of Pharmaceutical Sciences|August 21, 2014
Advanced kinetic analysis as a tool for formulation development and prediction of vaccine stabilityDidier Clénet, Frédéric Imbert, Patricia Probeck, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|August 18, 2018
Biophysical virus particle specific characterization to sharpen the definition of virus stabilityDidier Clénet, Tatiana Vinit, Damien Soulet, et al.
Biotechnology and Bioengineering|July 23, 2021
Full-length G glycoprotein directly extracted from rabies virus with detergent and then stabilized by amphipols in liquid and freeze-dried formsDidier Clénet, Léna Clavier, Benoît Strobbe, et al.
Plos One|June 11, 2025
Bayesian optimization and machine learning for vaccine formulation developmentLillian Li, Sung-In Back, Jian Ma, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 10, 2026
Formulation and stability design spaces for a new yellow fever vaccineDidier Clénet, Noémie Mansois, Yawen Guo, et al.
Pageof 2